Results 111 to 120 of about 304,767 (203)

Histological evaluation of hysterectomy specimens after NovaSure^® endometrial ablation in patients with atypical endometrial hyperplasia or endometrial carcinoma. [PDF]

Arch Gynecol Obstet
Schleicher OM, Hamzeh A, Gocke J, Poeschke P, Stuebs FA, Burghaus S, Heindl F, Hartmann A, Beckmann MW, Matek C, Emons J.   +10 more
europepmc   +1 more source

Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long.-term follow-up

, 2007
: Objectives Levonorgestrel (LNG), delivered locally into the uterine cavity has a profound effect on the endometrium. The aim of the study was to use a LNG intrauterine system to treat non-atypical and atypical endometrial hyperplasia in women and to ...
Verbeeck, G., Dhont, M., TJALMA, W, DE WEVERC, N, Wildemeersch, D., JANSSENS, D, WILDEMEERSCH, D, de Wever, N., Tjalma, Wiebren, Dhont, Marc, Janssens, D., PYLYSER, K, VERBEECK, G, Pylyser, K.   +13 more
core  

Pregnancy Outcomes Following Medical Therapy versus Levonorgestrel-Releasing Intrauterine System for Atypical Endometrial Hyperplasia. [PDF]

Ther Clin Risk Manag
Wang M, Zhao S, Yuan H, Zhao M, Hang C, Yuan R.   +5 more
europepmc   +1 more source

Oncological and reproductive outcomes following fertility-preserving treatment in mismatch repair-deficient endometrial cancer or atypical endometrial hyperplasia. [PDF]

BMC Womens Health
Zhang T, Yang J, Cao D, Yu M, Wu H, Xiang Y, Zhang X, Zong X, Zhang R, Jin X, Zhang K, Zheng J, Yang J.   +12 more
europepmc   +1 more source

Assessing the Reliability of Hysteroscopic Sampling Methods for Diagnosing Atypical Endometrial Hyperplasia. [PDF]

Cancers (Basel)
Giannella L, Piva F, Delli Carpini G, Di Giuseppe J, Giulietti M, Dugo E, Sopracordevole F, Del Fabro A, Clemente N, Gardella B, Bogani G, Brasile O, Martinello R, Caretto M, Ghelardi A, Albanesi G, Stevenazzi G, Venturini P, Papiccio M, Cannì M, Barbero M, Fambrini M, Maggi V, Uccella S, Spinillo A, Raspagliesi F, Greco P, Simoncini T, Petraglia F, Ciavattini A.   +29 more
europepmc   +1 more source

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy. [PDF]

Arch Gynecol Obstet, 2023
Ga H, Taguchi A, Honjoh H, Nishijima A, Eguchi S, Miyamoto Y, Sone K, Mori M, Osuga Y.   +8 more
europepmc   +1 more source

Oncological and Reproductive Outcomes of a Standardized Hysteroscopic Approach for the Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early-Stage Endometrial Cancer. [PDF]

Cancers (Basel)
Catena U, Bonetti Palermo E, De Bonis F, Bruni GM, Zorzi M, La Fera E, Dinoi G, Corrado G, Masciullo V, Fagotti A, Fanfani F.   +10 more
europepmc   +1 more source

Endometrial Cancer Incidence in Patients With Atypical Endometrial Hyperplasia According to Mode of Management. [PDF]

Cancer Diagn Progn, 2022
Barakat A, Ismail A, Chattopadhyay S, Davies Q.   +3 more
europepmc   +1 more source

Impact of gut microbiota on atypical endometrial hyperplasia and endometrial cancer: a comprehensive analysis of microbial composition and metabolomic profiling. [PDF]

BMC Microbiol
Peng H, Chen J, Shao Y, Li J, Chen M, He C, Sun J, Wang W, Cao X, Yang H, Zhou J, Wu Z.   +11 more
europepmc   +1 more source

Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review. [PDF]

J Gynecol Oncol, 2023
Murakami I, Machida H, Morisada T, Terao Y, Tabata T, Mikami M, Hirashima Y, Kobayashi Y, Baba T, Nagase S.   +9 more
europepmc   +1 more source